Inhibitor crystalline form and preparation method and use thereof
US9518059B2 · kind B2 · utility
1Cited by
0References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2015 |
| Grant date | Dec 13, 2016 |
| Priority date | — |
| Expiry date | Dec 2, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to new crystalline forms of the inhibitor, 5-fluoro-3-phenyl-2-[(S)-1-(9H-purin-6-ylamino)-propyl]-3H-quinazoline-4-one; the present invention also relates to methods for preparing the new crystalline forms of 5-fluoro-3-phenyl-2-[(S)-1-(9H-purin-6-ylamino)-propyl]-3H-quinazolin-4-one, pharmaceutical compositions containing the new crystalline forms thereof, and uses thereof for the treatment and/or prevention of diseases such as chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.